title: Direct antiviral agents for treatment-naïve patients with genotype 1 hepatitis C: A statistical model for comparing outcomes between real world and clinical trials.
authors.affiliation: HTA Unit, Regional Health Service, ESTAR-Tuscany Region, Florence, Italy. Electronic address: andrea.mesori.it@gmail.com.
authors.forename: Andrea
authors.initials: A
authors.lastname: Messori
authors.affiliation: Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy.
authors.forename: Maurizia R
authors.initials: MR
authors.lastname: Brunetto
authors.affiliation: Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy; Department of Biotechnology, University of Siena, Siena, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: De Luca
authors.affiliation: Department of Internal Medicine, Center for Systemic Manifestations of Hepatitis Viruses, University of Florence, Florence, Italy.
authors.forename: Anna Linda
authors.initials: AL
authors.lastname: Zignego
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001499:Bayes Theorem; D001562:Benzimidazoles / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005449:Fluorenes / Q000627:therapeutic use*; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D015233:Models, Statistical; D000069474:Sofosbuvir / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D005449:Fluorenes; C586541:ledipasvir; D000069474:Sofosbuvir